Correlation Between Eterna Therapeutics and Imunon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eterna Therapeutics and Imunon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eterna Therapeutics and Imunon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eterna Therapeutics and Imunon Inc, you can compare the effects of market volatilities on Eterna Therapeutics and Imunon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eterna Therapeutics with a short position of Imunon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eterna Therapeutics and Imunon.

Diversification Opportunities for Eterna Therapeutics and Imunon

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Eterna and Imunon is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Eterna Therapeutics and Imunon Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Imunon Inc and Eterna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eterna Therapeutics are associated (or correlated) with Imunon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Imunon Inc has no effect on the direction of Eterna Therapeutics i.e., Eterna Therapeutics and Imunon go up and down completely randomly.

Pair Corralation between Eterna Therapeutics and Imunon

Given the investment horizon of 90 days Eterna Therapeutics is expected to under-perform the Imunon. In addition to that, Eterna Therapeutics is 1.77 times more volatile than Imunon Inc. It trades about -0.33 of its total potential returns per unit of risk. Imunon Inc is currently generating about -0.09 per unit of volatility. If you would invest  103.00  in Imunon Inc on September 13, 2024 and sell it today you would lose (18.82) from holding Imunon Inc or give up 18.27% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Eterna Therapeutics  vs.  Imunon Inc

 Performance 
       Timeline  
Eterna Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eterna Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Imunon Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Imunon Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Eterna Therapeutics and Imunon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eterna Therapeutics and Imunon

The main advantage of trading using opposite Eterna Therapeutics and Imunon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eterna Therapeutics position performs unexpectedly, Imunon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Imunon will offset losses from the drop in Imunon's long position.
The idea behind Eterna Therapeutics and Imunon Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges